Related Experiment Video
Updated: May 28, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Leptospirosis-associated acute kidney injury: penicillin at the late stage is still controversial
E F Daher1, G B Silva, K L S de Abreu
1Post-Graduation Program in Medical Sciences, Department of Internal Medicine, School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. ef.daher@uol.com.br
What Is Known And Objective:
Some antimicrobial agents are active in vitro against Leptospiras. The use of penicillins at the late stage of leptospirosis is still controversial. We aimed to evaluate the use of penicillin in patients with leptospirosis-associated acute kidney injury (AKI).
Methods:
A retrospective study was conducted of patients with leptospirosis admitted to two hospitals in Fortaleza city, Brazil, between 1985 and 2008. AKI was defined according to the RIFLE and AKIN classifications. Patients were divided in two groups according to whether they were treated with a penicillin or not.
Results:
Two hundred and eighty-seven patients were included, with an average age of 36·8±15·6 years and mostly male (80·8%). One hundred and twelve patients (39%) received a penicillin. Patients treated with a penicillin were younger (32±14 years vs. 39±16 years, P=0·0002) and had a shorter hospital stay (8·4±5·0 vs. 11±7·7 days, P<0·0001). There was no difference in the onset of symptoms before hospital admission between the two groups (6·5±3·0 vs. 7·7±4·7, P=0·33). Systolic blood pressure was lower in the penicillin group (111±21 vs. 119±22 mmHg, P=0·04). AKI, need of dialysis and renal recovery at the time of hospital discharge were more frequent in patients who did not use a penicillin (P<0·05). Mortality was similar in both groups (11·6% vs. 13·7%, P=0·60).
Conclusion:
Treatment of leptospirosis with antibiotics, including the penicillin, remains controversial. The main benefit of using penicillin in the present study was a reduction in the length of hospital stay and fewer complications, such as AKI, but its use was not associated with a decrease in mortality. On balance of risks and benefits, we recommend the use of penicillin in late-stage leptospirosis.
Insights
Penicillin treatment for leptospirosis may reduce hospital stays and complications like acute kidney injury (AKI), but does not decrease mortality. Researchers recommend penicillin for late-stage leptospirosis based on a risk-benefit analysis.
Area of Science:
- Infectious Diseases
- Nephrology
- Pharmacology
Background:
- Leptospirosis is a bacterial infection with potential kidney complications.
- The efficacy of penicillin in treating late-stage leptospirosis, particularly with acute kidney injury (AKI), remains debated.
- Antimicrobial agents show in vitro activity against Leptospira.
Purpose of the Study:
- To evaluate the effectiveness of penicillin in patients with leptospirosis-associated acute kidney injury (AKI).
- To assess the impact of penicillin on clinical outcomes, including renal function and mortality, in leptospirosis patients.
Main Methods:
- Retrospective study of 287 patients with leptospirosis admitted to hospitals in Fortaleza, Brazil (1985-2008).
- Patients were categorized into two groups: those treated with penicillin and those not.
- Acute kidney injury (AKI) was classified using RIFLE and AKIN criteria.
Main Results:
- Patients treated with penicillin were younger and had shorter hospital stays.
- Penicillin use was associated with a lower incidence of AKI, need for dialysis, and improved renal recovery.
- No significant difference in mortality rates was observed between the penicillin and non-penicillin groups.
Conclusions:
- Penicillin treatment in late-stage leptospirosis may reduce hospital stay duration and complications like AKI.
- While not reducing mortality, penicillin offers benefits in managing leptospirosis-associated kidney injury.
- The study recommends penicillin use in late-stage leptospirosis, balancing risks and benefits.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Pyelonephritis I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
